Ads
related to: does dimethylamylamine cause heart problems in men over 50 yearswexnermedical.osu.edu has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
1,4-Dimethylamylamine (1,4-DMAA), also known as 1,4-dimethylpentylamine or as 5-methylhexan-2-amine, is a stimulant drug of the alkylamine family related to methylhexanamine (1,3-DMAA; geranamine). [ 1 ] [ 2 ] It is naturally present in geranium plants and has also been found in certain other plants.
[8] [9] Coronary artery disease and high blood pressure may play a role, but are not the primary cause. [ 5 ] [ 8 ] In many cases the cause remains unclear. [ 8 ] It is a type of cardiomyopathy , a group of diseases that primarily affects the heart muscle . [ 3 ]
Around one in four deaths each year are due to heart disease; that’s 655,000 people annually. A number of factors, says Salim Hayek, MD, a cardiologist at the Michigan Medicine Frankel ...
Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study. ... flow to the heart is what causes a heart attack, while blocked ...
Per the American Heart Association (AHA), alcohol is one of the leading causes of dilated cardiomyopathy. [2] However, multiple longitudinal studies have shown a paradoxical lowering of dilated cardiomyopathy with modest-to-moderate alcohol consumption. [2] ACM is a type of heart disease that occurs due to chronic alcohol consumption.
Tachycardia-induced cardiomyopathy (TIC) is a disease where prolonged tachycardia (a fast heart rate) or arrhythmia (an irregular heart rhythm) causes an impairment of the myocardium (heart muscle), which can result in heart failure.
This treatment extended over a period of one year (52 weeks). The researchers reported that the females lost a larger percentage of their body weight over the course of the study (9.6% versus 7.2%),